OpenVSafe by OpenVAERS
Search V-safe

5A7-95352-53700

2 vaccinations 5 coded responses 25 check-ins 5 free-text entries 2 call cases
Sex
Male
Age at first dose
41-45
ZIP prefix
981 / WA
Registered
2020-12-27
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-27
    Registered in v-safe
  2. 2020-12-27
    Dose 1 — Moderna
  3. 2020-12-27
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  5. 2020-12-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  6. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  7. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-03
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-10
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-17
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-01-20
    Dose 2 — Moderna
  14. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-01-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site erythema, Injection site pruritus, Injection site reaction, Skin ulcer — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Spontaneous ulcerative lesion 1cm in diameter, approximately 4cm adjacent to injection site, with area of erythema surrounding it and pruritis.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-22
    Report sent to call center — days 1–6 daily, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-01-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site haemorrhage, Skin haemorrhage, Skin lesion — Feeling: Good · Site: Pain, Swelling · Rash, not including the immediate area around the injection site
    Free text: Same lesion that I previously reported. It is unclear whether it is healing or not. It started bleeding when I removed the bandage this morning.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-01-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site infection — Feeling: Good · Site: Pain, Swelling, Itching
    Free text: Lesion next to the injection site is still open and oozing serous fluid. Slowly healing.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-01-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site pruritus, Injection site reaction, Scab, Skin lesion — Feeling: Good · Site: Pain, Swelling
    Free text: Erosive lesion adjacent to injection site. Now crusted, itching and healing.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-01-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-01-27
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-02-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-10
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-17
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-24
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-03-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-03-31
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  28. 2021-04-21
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-07-21
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2022-01-21
    Survey response — 12 months, dose 2
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: COVID-19 infection
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-01-21
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  32. 2022-01-24
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

DoseDateManufacturerCo-administered
12020-12-27Moderna
22021-01-20Moderna

Call center

2 call center cases

2 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-22

Systemic reaction (other): Spontaneous ulcerative lesion 1cm in diameter, approximately 4cm adjacent to injection site, with area of erythema surrounding it and pruritis.

2021-01-23

Systemic reaction (other): Same lesion that I previously reported. It is unclear whether it is healing or not. It started bleeding when I removed the bandage this morning.

2021-01-24

Systemic reaction (other): Lesion next to the injection site is still open and oozing serous fluid. Slowly healing.

2021-01-25

Systemic reaction (other): Erosive lesion adjacent to injection site. Now crusted, itching and healing.

Release 11 — 12 months, dose 2

2022-01-21

Symptoms: COVID-19 infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site haemorrhage ✓ ✓ ○
SROInjection site infection ✓ ✓ ✓
SROInjection site pruritus ✓ ✓ ✓
SROInjection site reaction ✓ ✓ ✓
SROScab ✓ ✓ ✓
SROSkin haemorrhage · · ✓
SROSkin lesion ✓ ✓ ✓
SROSkin ulcer ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release